Medium materiality4/10
BeOne Medicines price target raised to $470 by Jefferies
Why it may matterVerify against the original reporting
The target increase supports a bullish read, but the evidence is limited to a single analyst update.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Jefferies raised its ONC price target to $470, versus a posted price of $391.28. The analyst action signals a positive view, though it remains an opinion.
- Jefferies raised its ONC target to $470 from an unspecified prior level.
- Posted price: $391.28.
Key facts
- 01
Target: $470
- 02
Posted price: $391.28
- 03
Analyst firm: Jefferies
- 04
Analyst: Faisal Khurshid
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.